Boon san Teoh | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Ms. Boon san Teoh | Antimicrobial Resistance | Best Researcher Award 

Senior pharmacist | Singapore General Hospital | Singapore

Dr. Boon San Teoh is a distinguished clinician and researcher affiliated with Singapore General Hospital, Singapore’s leading medical institution recognized for excellence in clinical research and healthcare innovation. His professional expertise lies in infectious diseases and antimicrobial therapy, with a particular research interest in the clinical application and comparative effectiveness of advanced antibiotics such as daptomycin and linezolid in complex hospital settings. Dr. Teoh’s recent publication, “A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital,” featured in the journal Antibiotics (2025), reflects his commitment to improving patient outcomes through evidence-based medical practice and antimicrobial stewardship. His research contributions emphasize optimizing therapeutic interventions to address antibiotic resistance and ensure safer, more effective care. Beyond his scholarly endeavors, Dr. Teoh actively collaborates with multidisciplinary teams across microbiology, pharmacology, and hospital medicine, promoting integrated approaches to clinical challenges in infectious disease management. Through his engagement in research, mentorship, and collaborative healthcare improvement initiatives, Dr. Teoh contributes significantly to the advancement of medical science in Singapore and beyond. His academic integrity, clinical insight, and dedication to patient-centered research position him as a valuable contributor to global medical innovation, enhancing understanding of infectious disease dynamics and shaping strategies for better health outcomes worldwide.

Profiles: ORCID

Featured Publication

1. Teoh, B. S., Liew, Y. X., Wang, Y., Chung, S. J., & Tan, B. H. (2025, October 28). A retrospective study on the use of Daptomycin and Linezolid in Singapore General Hospital. Antibiotics, 14(11), 1088

Dr. Boon San Teoh’s research advances antimicrobial stewardship and patient safety through evidence-based evaluation of antibiotic therapies. His work at Singapore General Hospital contributes to optimizing clinical outcomes, reducing antimicrobial resistance, and strengthening global efforts toward sustainable healthcare innovation.

Hossain Mohammad Ismail | Disease Mapping | Young Researcher Award

Published on by Global Diseases Research

Assist. Prof. Dr. Hossain Mohammad Ismail | Disease Mapping | Young Researcher Award

Assistant Professor | Khulna University Of Engineering & Technology | Bangladesh

Dr. Mohammad Ismail Hossain, Ph.D., is an Assistant Professor at the Institute of Disaster Management, Khulna University of Engineering & Technology (KUET), Bangladesh, renowned for his interdisciplinary research in protected area management, disaster management policy, eco-tourism, and biodiversity conservation. With over 20 publications and 88 citations (h-index 5, i10-index 3), his work integrates geospatial technologies, ecosystem assessment, and sustainability science to address complex environmental and socio-economic challenges. Dr. Hossain’s influential studies, such as the SWOT analysis of forest protected area-based sustainable tourism development and Ecosystem Services of the Sundarbans, contribute significantly to the understanding of sustainable resource utilization and conservation planning in vulnerable regions. His research extends to flood susceptibility mapping, land-use change detection, water quality assessment, and livelihood adaptation in disaster-prone areas, offering actionable insights for policymakers and stakeholders. Collaborating with international scholars including Dr. Shinya Numata and Dr. Bishnu Prasad Khanal from Tokyo Metropolitan University, he has advanced cross-border environmental and conservation dialogues. His recent works emphasize remote sensing and GIS applications for natural resource management and disaster resilience, underscoring his commitment to science-based environmental governance. Through his scholarly endeavors, Dr. Hossain has made enduring contributions to sustainable development, ecosystem restoration, and disaster risk reduction, reinforcing his standing as a distinguished researcher and educator dedicated to fostering environmental resilience and sustainable futures in Bangladesh and beyond.

Profiles: Google Scholar | ORCID

Featured Publications

1. Hossain, M. I., & Khanal, B. P. (2020). SWOT analysis of forest protected area based sustainable tourism development: A case study in the Lawachara National Park, Bangladesh. Journal of Tourism and Hospitality Education, 10, 71–89.
Cited by: 28

2. Hossain, M. I., Nabi, M. R., Ansari, M. N. A., Latif, A., Mahmud, M., & Islam, M. S. (2016). Ecosystem services of the world’s largest mangrove forest Sundarban in Bangladesh. International Journal of Innovation and Scientific Research, 27(1), 9.
Cited by: 16

3. Nabi, M. R., Rashid, M. S., & Hossain, M. I. (2016). Historical bankline shifting since 1760s: A GIS and remote sensing based case study of Meghna river plate of Rennell’s atlas. International Journal of Scientific and Research Publications, 6(12), 473–483.
Cited by: 14

4. Das, O. C., Alam, M. J., Hossain, M. I., Hoque, M. M., & Barua, S. (2021). Factors determining the smallholder milk producers’ participation in contractual agreements: The case of North-West Bangladesh. International Journal of Sustainable Agricultural Research, 8(3), 164–179.
Cited by: 8

5. Hossain, M. I., Ansari, M. N. A., & Saika, U. (2017). Lake base urban recreation in Dhaka metropolitan area: Hatirjheel Lake as a potential case. International Journal of Research – Granthaalayah, 5(12), 266–274.
Cited by: 6

Evie Carchman | Cancer Prevention | Best Researcher Award

Published on by Global Diseases Research

Dr. Evie Carchman | Cancer prevention | Best Researcher Award 

Associate Professor | University of Wisconsin | United States

Dr. Evie H. Carchman is a distinguished clinician-scientist affiliated with the William S. Middleton Memorial Veterans Hospital in Madison, United States, recognized for her extensive contributions to colorectal and anal disease research. With 68 publications and over 3,700 citations. Dr. Carchman’s work has significantly advanced understanding in areas such as anal cancer prevention, dysplasia detection, and surgical innovation. Her studies on PIK3CA mutations in anal dysplasia, peristaltic contractility in ileal pouch-anal anastomosis (IPAA), and CD4/CD8 ratio as a biomarker in veterans with HIV highlight her multidisciplinary approach that bridges oncology, immunology, and gastrointestinal surgery. As an author and collaborator with over 3,000 co-researchers worldwide, she exemplifies scientific collaboration aimed at improving patient outcomes and translational medicine. Dr. Carchman’s recent publications in reputed journals such as the International Journal of Colorectal Disease, Scientific Reports, and Diseases of the Colon and Rectum emphasize her leadership in identifying novel therapeutic sensitivities in cancer organoids and exploring minimally invasive treatments, including laser hair removal as a primary therapy for pilonidal disease. Her dedication to veterans’ healthcare and public health innovation underscores a career defined by scientific rigor, compassion, and commitment to advancing surgical science and cancer prevention. Through her impactful research, mentorship, and international collaborations, Dr. Evie H. Carchman continues to shape the global landscape of colorectal oncology and preventive medicine, contributing meaningfully to both academic excellence and societal well-being.

Profiles: Scopus | ORCID 


Featured Publications




1. Johnson, H. R., Dietmann, E. C., Praska, C. E., Dennison, K. L., McGregor, S. M., Suter, W., Leverson, G., Murtaza, M., & Carchman, E. H. (2025, November). Detection of PIK3CA mutations in anal dysplasia. Journal of Surgical Research. Advance online publication.


2. Hewitt, A. J., Freeman, M. J., Hayden, D. M., Carchman, E. H., Schweizer, M. L., & Sanger, C. B. (2025, November). Evaluation of anal cancer screening practices among a national cohort of veterans with HIV. Diseases of the Colon & Rectum. Advance online publication.


3. DeZeeuw, A. K., Bassetti, M. F., Carchman, E. H., Heise, C. P., Hayden, D., Lawson, E. H., Sanger, C. B., King, R., LoConte, N. K., Lubner, S. J., et al. (2024, September 3). Carboplatin and paclitaxel chemoradiation for localized anal cancer in patients not eligible for mitomycin and 5-fluorouracil. Cancers, 16(17), 3062. 
Cited by: 1


4. Lozar, T., Wang, W., Gavrielatou, N., Christensen, L., Lambert, P. F., Harari, P. M., Rimm, D. L., Burtness, B., Grasic Kuhar, C., & Carchman, E. H. (2023, November 25). Emerging prognostic and predictive significance of stress keratin 17 in HPV-associated and non HPV-associated human cancers: A scoping review. Viruses, 15(12), 2320. 
Cited by: 4














Dr. Evie H. Carchman’s pioneering research in colorectal and anal cancer prevention integrates molecular oncology, surgical innovation, and translational science to improve patient outcomes. Her work advances global cancer prevention strategies through early detection, precision medicine, and evidence-based clinical practice.











	


	

	






	
	

		


Hans Rudolf Pfaendler | Microbiology | Best Researcher Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Prof. Dr. Hans Rudolf Pfaendler | Microbiology | Best Researcher Award 


Professor Emeritus | University of Munich | Germany
















Prof. Dr. Hans Rudolf Pfaendler is a distinguished researcher and faculty member at Ludwig-Maximilians-Universität München, Germany, with a focus on microbiology and chemical sciences. Over his career, he has authored 35 publications that have collectively garnered 660 citations, reflecting both the quality and impact of his work. His research spans innovative methodologies in microbiology, including the development of the CarbaLux test for detecting carbapenemases and AmpC beta-lactamases, as well as contributions to organic chemistry, such as novel formaldehyde derivatives and vicinal diamination of terminal olefins. Pfaendler has collaborated with a broad network of 46 co-authors, highlighting his commitment to interdisciplinary and international research initiatives. His work has significantly advanced diagnostic techniques and synthetic chemistry, providing tools that are not only academically influential but also societally relevant, particularly in addressing antimicrobial resistance and chemical synthesis challenges. Recognized for both methodological innovation and practical applications, his scholarship bridges fundamental research and translational impact, underlining his standing as a leading figure in his field.


Profiles: Scopus | ORCID


Featured Publications


1. Pfaendler, H. R. (1994). ß-Lactame – ein aktueller Überblick: The Organic Chemistry of β-Lactams. Von G. I. Georg. VCH, Weinheim 1993. 381 S., 39 Abb., 68 Tab., geb., DM 189,-. ISBN 3-527-28188-6. Nachrichten aus Chemie, Technik und Laboratorium, 42(1), 29–30.Pf.


2. Pfaendler, H. R., Hendel, W., & Nagel, U. (1992). Stable Oxapenem-3-Carboxylic Acids – A New Class of β-Lactam Antibiotics. Influence of 2- and 6-Alkyl Substituents. Zeitschrift für Naturforschung B, 47(7–8), 726–732


3. Pfaendler, H., Hartung, R., Golz, G., Schlaf, S., Silvennoinen, G., Polborn, K., & Mayer, P. (2009). A Simple and Efficient Preparation of Novel Formaldehyde Derivatives. Synthesis, 2009(1), 9–16.


4. Pfaendler, H. R. (1990). Robinsonade: „Robert Robinson ‐ Chemist Extraordinary”. Von Trevor I. Williams. Oxford University Press (Clarendon Press Oxford) 1990. 201 S., 13 Fotos, geb. $ 25.00, ISBN 0‐19‐858180‐7. Nachrichten aus Chemie, Technik und Laboratorium, 38(10), 318–319.


5. Pfaendler, H. R., Weishaupt, R., & Meffert, H. (2000). Synthesis and Biological Activities of an α-Methyl and a β-Methyl Carbapenem and the Corresponding Unsubstituted Compound. Bioorganic & Medicinal Chemistry Letters, 10(12), 1417–1420.
















Prof. Dr. Hans Rudolf Pfaendler’s work advances the rapid detection and characterization of antimicrobial resistance through innovative diagnostic tools, such as the CarbaLux test for carbapenemases and AmpC beta-lactamases. By enabling faster, more accurate identification of resistant bacterial strains, his research supports improved clinical decision-making, enhances patient outcomes, and informs global strategies to combat antibiotic resistance. This contribution bridges fundamental microbiology with practical healthcare applications, promoting both scientific understanding and societal impact.






































	


	

	






	
	

		


Mahfuza	Nasrin | Microbiology | Best Researcher Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Assoc. Prof. Dr. Mahfuza Nasrin | Microbiology | Best Researcher Award 


Associate Professor | Uttara Adhunik Medical College | Bangladesh


Mahfuza Nasrin is an Associate Professor specializing in antimicrobial resistance and antimicrobial stewardship, with a strong focus on clinical microbiology and infection control. Her research portfolio encompasses the bacteriological profiling of bloodstream, wound, and urinary tract infections, as well as the characterization of antimicrobial susceptibility patterns in Bangladesh. She has contributed to over ten peer-reviewed publications, which have collectively garnered 16 citations, reflecting her growing impact in the field. Nasrin has collaborated with national and international colleagues on studies that map antimicrobial resistance trends across diverse clinical settings, highlighting variations between low-, middle-, and high-income regions and offering critical insights for global public health strategies. Her recent work emphasizes the emerging threat of carbapenem-resistant Enterobacterales and the importance of establishing effective infection prevention and control protocols in tertiary care hospitals. Beyond her research, Nasrin’s contributions advance antimicrobial stewardship and inform clinical decision-making, with tangible societal impact in improving patient outcomes and guiding evidence-based policy in healthcare institutions. She continues to engage in collaborative studies and preprints, demonstrating a commitment to innovation, knowledge dissemination, and the global fight against antimicrobial resistance.


Profiles: Scopus | Google Scholar | ORCID


Featured Publications


1. Nasrin, M., Begum, M. F., Rahman, F., Karim, R., Bhuiyan, M. M., & Nawal, N. (2025). Antibiogram and antimicrobial susceptibility pattern of bacterial isolates from a tertiary care hospital in Dhaka. Archives of Microbiology & Immunology, 9(1), 31–37. Cited: 1


2. Nawal, D. N., Begum, M. F., Nasrin, M., Rahman, F., Karim, R., Alam, M. S., … & Alam, D. M. S. (2025). Bacteriological profile and antibiotic susceptibility pattern of clinical isolates from a tertiary care hospital in Dhaka, Bangladesh. Fortune Journal of Health Sciences, 8, 668–674. Cited: 1


3. Nasrin, M., Begum, F., Sujan, M. J., Barua, H. T., Habib, Z. H., Rizvi, S. M. S., … (2025). Bacterial profile and antimicrobial resistance pattern from different clinical specimens at Uttara Adhunik Medical College Hospital, Dhaka. Preprints. Cited: 1


4. Nasrin, M., Begum, M. F., Karim, R., Alam, M. S., & Rahman, F. (2021). Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among bloodstream infection suspected patients attending in a referral hospital. Bangladesh Journal of Medical Microbiology, 15(2), 5–11. Cited: 6


5. Begum, M. F., Nasrin, M., & Alam, M. S. (2020). Bacteriological profile and antibiotic susceptibility patterns of wound infections at Uttara Adhunik Medical College Hospital, Dhaka. Bangladesh Journal of Medical Microbiology, 14(1), 15–19. Cited: 5


Dr. Mahfuza Nasrin’s work on antimicrobial resistance and bacterial infection profiling advances understanding of pathogen susceptibility patterns in clinical settings, directly informing antibiotic stewardship and public health strategies in Bangladesh and globally. Her research supports evidence-based interventions to combat drug-resistant infections, improving patient outcomes and guiding policy in infectious disease management.



	


	

	






	
	

		


Xiaolin Hou | Veterinary Pharmacology | Best Researcher Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Mr. Xiaolin Hou | Veterinary Pharmacology | Best Researcher Award 


Professor | Beijing University of Agriculture | China






























Dr. Xiaolin Hou is a distinguished researcher affiliated with Beijing University of Agriculture, specializing in veterinary virology, immunology, and nanobiotechnology applications in animal health. With a prolific portfolio of 58 publications and over 1,200 citations, Dr. Hou has significantly contributed to the understanding of viral pathogenesis and host immune modulation, particularly in chronic hepatitis B and porcine reproductive and respiratory syndrome virus. His research emphasizes innovative approaches to disease prevention and therapeutic interventions, including nanoparticle-mediated drug delivery, quantum dot polymer inhibitors, and advanced immunoassay techniques for mycotoxin detection. Collaborating extensively with a global network of 174 co-authors, Dr. Hou integrates multidisciplinary expertise across molecular biology, food safety, and pharmaceutical sciences to develop practical solutions for veterinary and public health challenges. His work demonstrates a consistent focus on enhancing immune responses, suppressing pathogenic mechanisms, and improving disease diagnostics, reflecting both academic rigor and societal impact. Notably, Dr. Hou’s research bridges fundamental science with applied technologies, fostering advancements in animal therapeutics, vaccine development, and food safety monitoring. Recognized for both methodological innovation and translational relevance, his contributions continue to shape contemporary approaches in veterinary pharmacology and virology research on an international scale.


Profiles: Scopus | ORCID


















Featured Publications
























1. Han, C., Xu, W., Wang, J., Hou, X., Zhou, S., Song, Q., Liu, X., & Li, H. (2023). Porcine circovirus 2 increases the frequency of transforming growth factor-β via the C35, S36 and V39 amino acids of the ORF4. Viruses, 15(7), 1602.


2. Liu, X., Wang, Y., Han, C., Li, Q., Hou, X., Song, Q., Zhou, S., & Li, H. (2022). TGF-β from the porcine intestinal cell line IPEC-J2 induced by porcine circovirus 2 increases the frequency of Treg cells via the activation of ERK (in CD4⁺ T cells) and NF-κB (in IPEC-J2). Viruses, 14(11), 2466


3. Hou, X. (2022). A berberine hydrochloride–carboxymethyl chitosan hydrogel protects against Staphylococcus aureus infection in a rat mastitis model. Carbohydrate Polymers, 282, 118910.


4. Hou, X. (2022). Lithium chloride inhibits infectious bronchitis virus-induced apoptosis and inflammation. Microbial Pathogenesis, 162, 105352.


5. Hou, X. (2021). Antibacterial activity and membrane-targeting mechanism of aloe-emodin against Staphylococcus epidermidis. Frontiers in Microbiology, 12, 621866.










Dr. Xiaolin Hou’s research advances animal and human health through innovative applications of nanotechnology, immunoassays, and antiviral strategies. By elucidating molecular mechanisms in viral infections and immune modulation, their work contributes to disease prevention, therapeutic development, and global food safety, bridging fundamental science with practical solutions for public health and veterinary medicine.











	


	

	






	
	

		


Xin Su | Infectious Diseases | Best Researcher Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Prof. Dr. Xin Su | Infectious Diseases | Best Researcher Award 


Chief Physician | Nanjing Drum Tower Hospital | Best Researcher Award
















Dr. Xin Su is a distinguished researcher affiliated with Nanjing University, China, recognized for significant contributions in the fields of [specific research area—can be added if known, e.g., virology, immunology, or molecular biology]. With an extensive body of work comprising 128 peer-reviewed publications and over 2,670 citations, Dr. Su has demonstrated sustained scholarly impact, reflected in an h-index of 28. Their research encompasses both fundamental and applied dimensions, advancing understanding in [insert general field, e.g., biomedical sciences] while fostering innovations with potential societal benefits, such as [insert general societal impact, e.g., improving public health, disease prevention, or therapeutic development]. Dr. Su actively collaborates with a global network of over 524 co-authors, promoting interdisciplinary approaches and international research exchange. Their work has been featured in high-impact journals and cited widely, underscoring the relevance and rigor of their scientific contributions. Beyond academic publications, Dr. Su’s research influences policy and practice, exemplifying a commitment to translating scientific knowledge into tangible societal outcomes. This combination of prolific output, collaborative engagement, and real-world applicability positions Dr. Su as a leading figure in their field, advancing both knowledge and its practical application on a global scale.


Profiles: Scopus | Orcid


Featured Publications












1. Wei, S., Su, X., Pan, Y., Zheng, Y., Dong, X., Hu, X., … Shi, Y. (2020). Postoperative antifungal treatment of pulmonary cryptococcosis in non-HIV-infected and non-transplant-recipient patients: A report of 110 cases and literature review. Open Forum Infectious Diseases, 7(1), [Article ofaa004].


2. Zhao, J., Zhu, M., Jiang, H., Shen, S., Su, X., & Shi, Y. (2019). Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: A potential therapy against pathogenic influenza virus. Scientific Reports, 9, [Article 41760].


3. Zhao, J. N., Shi, Y., Yuan, D., Qunli, S., Wang, W., & Su, X. (2020). A case of Penicillium citrinum infection associated acute fibrinous and organizing pneumonitis. American Journal of Respiratory and Critical Care Medicine. WOS:000556622801444


4. Zhao, J., Shi, Y., Yuan, D., Shi, Q., Wang, W., & Su, X. (2020). A case report of fungal infection associated acute fibrinous and organizing pneumonitis. BMC Pulmonary Medicine, 20(1), [Article 1145]


5. Chen, B., Zhong, H., Ni, Y., Liu, L., Zhong, J., & Su, X. (2020). Epidemiological trends of coronavirus disease 2019 in China. Frontiers in Medicine, 7, [Article 259].


Dr. Xin Su’s research advances understanding in their field by driving innovative solutions with broad applications in science and industry, fostering global collaboration, and contributing to sustainable progress in technology and human health.







	


	

	






	
	

		


Peter Asaga Mac | Infectious diseases | Best Researcher Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Dr. Peter Asaga Mac | Infectious diseases | Best Researcher Award 


Senior clinical research fellow | University Hospital Freiburg | Germany
















Dr. Peter Asaga Mac is a dedicated researcher at Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany, specializing in infectious and zoonotic diseases. His scientific work focuses on understanding the epidemiology, immune response, and transmission dynamics of emerging viral infections, particularly mosquito-borne diseases such as Chikungunya and Dengue. Through a combination of field-based studies, serological analyses, and molecular surveillance, Dr. Mac investigates how co-circulating arboviruses interact within populations and contribute to public health challenges in endemic regions, especially in Africa. His notable publication, “An Undetected Expansion, Spread, and Burden of Chikungunya and Dengue Cocirculating Antibodies in Nigeria” (Zoonotic Diseases, 2024), provides valuable insight into the unnoticed expansion of these viruses and their long-term implications for disease control strategies. Dr. Mac’s research is characterized by its translational value—bridging scientific discovery with actionable health interventions to improve epidemic preparedness and response. His collaborations with international scientists strengthen global efforts to monitor zoonotic threats and develop more resilient surveillance systems. Despite being an early-career researcher, his contributions are gaining recognition within the academic community. With 3 publications, 14 citations  and an h-index of 2, Dr. Mac’s growing academic footprint reflects his potential to make lasting contributions to infectious disease research, particularly in the areas of viral immunology, epidemiological modeling, and global health resilience. His commitment to evidence-based solutions continues to shape a better understanding of emerging diseases and their impact on human health worldwide.


Profiles: Scopus | ORCID | Google Scholar


Featured Publications


1. Chackalackal, D. J., Al-Aghbari, A. A. A., Jang, S. Y., Ramirez, T. R., Vincent, J., Joshi, A., et al. (2021). The Covid-19 pandemic in low- and middle-income countries: Who carries the burden? Review of mass media and publications from six countries. Pathogens and Global Health, 115(3), 178–187.
Cited by: 49


2. Mac, P. A., Suleiman, A. C., & Airiohuodion, P. E. (2019). High prevalence of hepatitis B virus infection among pregnant women attending antenatal care in Central Nigeria. Journal of Infectious Diseases and Epidemiology, 5(1), 068.
Cited by: 34


3. Mac, P. A., Asheadzi, H. F., Gideon, A., Thaker, P., & Airiohuodion, P. (2019). Prevalence of Plasmodium falciparum among Nigerians in Abuja and Central States: A comparative analysis of sensitivity and specificity using rapid diagnostic test and microscopy. International Journal of Tropical Diseases, 1, 014.
Cited by: 22


4. Mac, P. A., Kroeger, A., & Airiohuodion, P. E. (2019). Needs assessment of emergency medical and rescue services in Abuja/Nigeria and environs. BMC Emergency Medicine, 19(78), 8.
Cited by: 21


5. Mac, P. A., Airiohuodion, P. E., Yako, A. B., et al. (2022). The seroprevalence and hidden burden of chikungunya endemicity and malaria mono- and coinfection in Nigeria. International Journal of Environmental Research and Public Health, 19(15), 8896.
Cited by: 19















	


	

	






	
	

		


Bruno Vieira | Immunopharmacology | Young Scientist Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Dr. Bruno Vieira | Immunopharmacology | Young Scientist Award 


Researcher | Instituto Estadual do Cérebro Paulo Niemeyer | Brazil
















Dr. Bruno Marques Vieira’s research is centered on the intersecting fields of immunopharmacology, neuroimmunology, and tumor immunology, with a strong focus on understanding immune cell behavior in health and disease. His work explores the complex roles of eosinophils and neutrophils in inflammatory and tumor processes, particularly their contribution to immune regulation within the brain tumor microenvironment. By integrating in vivo, in vitro, and histopathological methodologies, his studies investigate immune cell signaling pathways, the dynamics of inflammation, and the pharmacological modulation of immune responses. Dr. Vieira’s research emphasizes the mechanisms through which immune cells interact with tumor cells and how these interactions can be harnessed to develop novel therapeutic strategies. His investigations aim to identify molecular targets and immune biomarkers that have potential relevance for glioblastoma and other neuroinflammatory or oncological conditions. With 18 publications, 57 citations, and an h-index of 5, Dr. Vieira contributes significantly to advancing translational immunology by bridging fundamental immunological discoveries with clinical applications in neuro-oncology, highlighting the therapeutic potential of immune modulation in cancer treatment. Through his research, he continues to advance scientific understanding of immune–tumor communication, inflammation, and pharmacological intervention, supporting the development of innovative approaches for treating brain cancers and other immune-mediated diseases.
















Profiles: Scopus | ORCID


Featured Publications


1. Vieira, B. M., de São José, V. S., Soares, P. N., & Moura-Neto, V. (2023). Eosinophils induces glioblastoma cell suppression and apoptosis—Roles of GM-CSF and cysteinyl-leukotrienes. International Immunopharmacology


2. Kast, R. E., Vieira, B. M., & Silva, E. B. da. (2025). A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. International Journal of Molecular Sciences, 26(13), 6158.


3. Vieira, B. M., Paiva, M. B., Gaspar-Elsas, M. I., & Xavier-Elsas, P. P. (2025). Coordinated regulation of eosinophil production and migration by glucocorticoids, prostaglandins, and cysteinyl-leukotrienes. International Immunopharmacology, 148, 114067. 

Cited by: 1


4. Vieira, B. M., Almeida, B. F., & Machado, M. P. (2025). Eosinophil and B-cell dynamics in the milky spots from Schistosoma mansoni-infected mice: comparison with spleen and bone marrow, and extramedullary eosinopoiesis. International Immunology, 37(3), 173–185. 

Cited by: 1


5. de São José, V. S., Vieira, B. M., Neto, V. M., & Lima, L. M. (2024). Repurposing Osimertinib and Gedatolisib for Glioblastoma Treatment: Evidence of Synergistic Effects in an In Vitro Phenotypic Study. Pharmaceuticals, 17(12), 1623.

Cited by: 2



	


	

	






	
	

		


Sivabalaselvamani Dhandapani | Diagnostic Tools | Best Researcher Award
			

				Published on  by Global Diseases Research			

		
	


	

		
Dr. Sivabalaselvamani Dhandapani | Diagnostic Tools | Best Researcher Award 


Associate Professor | Presidency University | India
















Dr. D. Sivabalaselvamani, MCA, Ph.D. (SET Qualified), is an accomplished academician and researcher currently serving as an Associate Professor at the School of Information Science, Presidency University, Bengaluru, with a total experience of over 17.5 years. His research expertise spans artificial intelligence, data science, vehicular ad-hoc networks, and deep learning applications in healthcare and engineering. He has authored more than 54 Scopus-indexed papers and 70 Google Scholar publications, accumulating 271 citations and achieving an h-index of 7, reflecting his growing scholarly impact. He has also published a book titled “Introduction to AI and Data Science Applications for Engineering” with CRC Press (Taylor & Francis Group, 2025), co-authored with eminent international researchers. His innovative work has led to three published patents and two funded research projects, including one under the ICMR Ad-hoc Research Scheme. A recipient of multiple academic awards, including the Best Faculty Award (2013-14), Dr. Sivabalaselvamani continues to contribute significantly to interdisciplinary research, fostering innovation and guiding emerging scholars in computing and data-driven technologies.










Profiles: Scopus | Google Scholar | ORCID














Featured Publications


1. Cyril, C. P. D., Beulah, J. R., Subramani, N., Mohan, P., Harshavardhan, A., & Sivabalaselvamani, D. (2021). An automated learning model for sentiment analysis and data classification of Twitter data using balanced CA-SVM. Concurrent Engineering, 29(4), 386–395. Cited by: 110




2. Manikandan, S., Chinnadurai, M., Vianny, D. M. M., & Sivabalaselvamani, D. (2020). Real time traffic flow prediction and intelligent traffic control from remote location for large-scale heterogeneous networking using TensorFlow. International Journal of Future Generation Communication and Networking, 13. Cited by: 40


3. Nanthini, K., Sivabalaselvamani, D., Chitra, K., Gokul, P., & KavinKumar, S. (2023). A survey on data augmentation techniques. In 2023 7th International Conference on Computing Methodologies and Communication (ICCMC).

Cited by: 38


4. Sivabalaselvamani, D., & Soorya, B. (2020). Convolution Neural Network based Specialized Restaurant Rating Using Facial Expression Detection. In 2020 International Conference on Inventive Computation Technologies (ICICT).

Cited by: 22


5. Sridharan, M., Arulanandam, D. C. R., Chinnasamy, R. K., & Sivabalaselvamani, D. (2021). Recognition of font and Tamil letter in images using deep learning. Cited by: 20